These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 37380058

  • 1. Comparison and Development of Immunohistochemical Diagnostic Criteria for Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Sakamoto K, Baba S, Okumura Y, Momose S, Ono S, Tonooka A, Ichinohasama R, Takakuwa E, Nakasone H, Ohshima K, Takeuchi K.
    Mod Pathol; 2023 Oct; 36(10):100253. PubMed ID: 37380058
    [Abstract] [Full Text] [Related]

  • 2. Optimized immunohistochemical panel to differentiate myeloid sarcoma from blastic plasmacytoid dendritic cell neoplasm.
    Sangle NA, Schmidt RL, Patel JL, Medeiros LJ, Agarwal AM, Perkins SL, Salama ME.
    Mod Pathol; 2014 Aug; 27(8):1137-43. PubMed ID: 24390220
    [Abstract] [Full Text] [Related]

  • 3. Expanding the Immunophenotypic Spectrum of Neoplastic and Reactive Plasmacytoid Dendritic Cells.
    Wu SJ, Sadigh S, Lane AA, Pinkus GS.
    Am J Clin Pathol; 2023 May 02; 159(5):455-463. PubMed ID: 36880313
    [Abstract] [Full Text] [Related]

  • 4. A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients.
    Gong C, Liu Y, Zhang M.
    Ther Adv Hematol; 2024 May 02; 15():20406207241251602. PubMed ID: 38832237
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic management of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in close interaction with therapeutic considerations.
    Shumilov E, Mazzeo P, Ghandili S, Künstner A, Weidemann S, Banz Y, Ströbel P, Pollak M, Kolloch L, Beltraminelli H, Kerkhoff A, Mikesch JH, Schliemann C, Haase D, Wulf G, Legros M, Lenz G, Feldmeyer L, Pabst T, Witte H, Gebauer N, Bacher U.
    Ann Hematol; 2024 May 02; 103(5):1587-1599. PubMed ID: 38194088
    [Abstract] [Full Text] [Related]

  • 6. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Sukswai N, Aung PP, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Nagarajan P, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Medeiros LJ, Khoury JD.
    Am J Surg Pathol; 2019 Oct 02; 43(10):1429-1437. PubMed ID: 31261288
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Wang W, Xu J, Khoury JD, Pemmaraju N, Fang H, Miranda RN, Yin CC, Hussein SE, Jia F, Tang Z, Hu S, Konopleva M, Medeiros LJ, Wang SA.
    Cancers (Basel); 2022 Jul 11; 14(14):. PubMed ID: 35884435
    [Abstract] [Full Text] [Related]

  • 9. Blastic plasmacytoid dendritic cell neoplasm of skin, a rare dermatohematologic malignancy-A case report.
    Edjtemaei R, Ghanadan A, Ameli F.
    Clin Case Rep; 2024 Sep 11; 12(9):e9398. PubMed ID: 39210931
    [Abstract] [Full Text] [Related]

  • 10. A blastic plasmacytoid dendritic cell neoplasm-like immunophenotype is negatively associated with CEBPA bZIP mutation and predicts unfavorable prognosis in acute myeloid leukemia.
    Song J, Li W, Bai Y, Zhou P, Niu J, Niu X, Liu Y, Liu X, Drokow EK, Sun K, Zhou H.
    Ann Hematol; 2024 Feb 11; 103(2):463-473. PubMed ID: 38183444
    [Abstract] [Full Text] [Related]

  • 11. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Khoury JD.
    Curr Hematol Malig Rep; 2018 Dec 11; 13(6):477-483. PubMed ID: 30350260
    [Abstract] [Full Text] [Related]

  • 12. Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Jain A, Sweet K.
    J Natl Compr Canc Netw; 2023 May 11; 21(5):515-521. PubMed ID: 37156483
    [Abstract] [Full Text] [Related]

  • 13. Novel Therapeutic Approaches in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Era of Targeted Therapy.
    Wilson NR, Konopleva M, Khoury JD, Pemmaraju N.
    Clin Lymphoma Myeloma Leuk; 2021 Nov 11; 21(11):734-740. PubMed ID: 34226167
    [Abstract] [Full Text] [Related]

  • 14. Blastic Plasmacytoid Dendritic Cell Neoplasm; A Report of Three Cases.
    Safaei A, Monabati A, Mokhtari M, Solhjoo F, Montazer M.
    Iran J Med Sci; 2019 Jan 11; 44(1):74-78. PubMed ID: 30666080
    [Abstract] [Full Text] [Related]

  • 15. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
    Zhang X, Sun J, Yang M, Wang L, Jin J.
    Crit Rev Oncol Hematol; 2020 May 11; 149():102928. PubMed ID: 32234682
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm.
    Hwang K, Park CJ, Jang S, Chi HS, Huh JR, Lee JH, Suh C, Lee KH.
    Histopathology; 2013 Apr 11; 62(5):764-70. PubMed ID: 23470050
    [Abstract] [Full Text] [Related]

  • 17. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
    Riaz W, Zhang L, Horna P, Sokol L.
    Cancer Control; 2014 Oct 11; 21(4):279-89. PubMed ID: 25310209
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinical Characteristics and Diagnosis of Acute Myeloid Leukemia with CD56-Blastic Plasmacytoid Dendritic Cell Neoplasm.
    Zhang X, Wu Y, Li C, Shen K, Li R.
    Clin Lab; 2023 Jun 01; 69(6):. PubMed ID: 37307129
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.